{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:45:00Z","timestamp":1791193500638,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.healun.2003.05.002","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T08:15:59Z","timestamp":1123834559000},"page":"1076-1080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Monitoring C2 Level Predicts Exposure in Maintenance Lung Transplant Patients Receiving the Microemulsion Formulation of Cyclosporine (Neoral)"],"prefix":"10.1016","volume":"24","author":[{"given":"Peter","family":"Jaksch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Neuhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sarahrudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Seweryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Wisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2003.05.002_bib1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9610(97)00004-4","article-title":"The past, present and future of lung transplantation","volume":"173","author":"Grover","year":"1997","journal-title":"Am J Surg"},{"key":"10.1016\/j.healun.2003.05.002_bib2","unstructured":"ISHLT registry report 2000. http:\/\/www.ishlt.org. Accessed 10 June 2002."},{"key":"10.1016\/j.healun.2003.05.002_bib3","unstructured":"UNOS transplant patient datasource 2000. http:\/\/www.patients.unos.org. Accessed 10 June 2002."},{"key":"10.1016\/j.healun.2003.05.002_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00041552-200111000-00006","article-title":"Progress in the clinical application of immunosuppressive drugs in renal transplantation","volume":"10","author":"Wilkinson","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.healun.2003.05.002_bib5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00007890-199602270-00008","article-title":"Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation\u2014early risk factors","volume":"61","author":"Sharples","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2003.05.002_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1053-2498(01)00360-6","article-title":"Risk factors for bronchiolitis obliterans","volume":"21","author":"Sharples","year":"2002","journal-title":"Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.05.002_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1385\/IR:24:2:177","article-title":"Lung transplantation and bronchiolitis obliterans","volume":"24","author":"McKane","year":"2001","journal-title":"Immunol Res"},{"key":"10.1016\/j.healun.2003.05.002_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/000456329403100503","article-title":"Methodological and clinical aspects of cyclosporin monitoring","volume":"31","author":"Holt","year":"1994","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.healun.2003.05.002_bib9","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1097\/00007890-200112150-00001","article-title":"Clinical status of lung transplantation","volume":"72","author":"DeMeo","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2003.05.002_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0022-5223(19)35031-7","article-title":"Pulmonary transplantation","volume":"103","author":"de Hoyos","year":"1992","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2003.05.002_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007890-199907150-00011","article-title":"Neoral monitoring by simplified sparse sampling area under the concentration-time curve","volume":"68","author":"Mahalati","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2003.05.002_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1681\/ASN.V124828","article-title":"Approaching the therapeutic window for cyclosporine in kidney transplantation","volume":"12","author":"Mahalati","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2003.05.002_bib13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00007890-199904270-00008","article-title":"Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection","volume":"67","author":"Grant","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2003.05.002_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1399-0012.1998.tb01098.x","article-title":"Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy","volume":"12","author":"Cantarovich","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2003.05.002_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1034\/j.1399-3046.1999.00058.x","article-title":"Sandimmune to Neoral conversion and value of abbreviated AUC monitoring in stable pediatric kidney transplant recipients","volume":"3","author":"Kelles","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2003.05.002_bib16","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1016\/S0041-1345(01)02318-1","article-title":"Neoral C2 Monitoring in pediatric liver transplant recipients","volume":"33","author":"Dunn","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2003.05.002_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S1053-2498(01)00272-8","article-title":"A limited sampling strategy for cyclosporine area under the curve monitoring in lung transplant recipients","volume":"20","author":"Dumont","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.05.002_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00007691-199902000-00004","article-title":"Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients","volume":"21","author":"Trull","year":"1999","journal-title":"Ther Drug Monit"},{"issue":"suppl","key":"10.1016\/j.healun.2003.05.002_bib19","first-page":"399","article-title":"Monitoring of 2-hour Neoral absorption in renal transplantation shows low incidence of acute rejection in the early post-graft period","volume":"2","author":"Pfeffer","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2003.05.002_bib20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/00007890-200203270-00022","article-title":"Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on two-hour post dose levels (C2)","volume":"73","author":"Levy","year":"2002","journal-title":"Transplantation"},{"issue":"suppl","key":"10.1016\/j.healun.2003.05.002_bib21","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/00007890-200205151-00003","article-title":"Patient management by Neoral C2 monitoring","volume":"73","author":"Levy","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2003.05.002_bib22","first-page":"285","article-title":"Relative bioavailability of cyclosporin from conventional and microemulsion formulations of heart-lung transplant candidates with cystic fibrosis","volume":"48","author":"Tan","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.healun.2003.05.002_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1053-2498(01)00523-X","article-title":"Comparison of cyclosporin pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and for other conditions","volume":"21","author":"Vervier","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.05.002_bib24","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/archinte.1993.00410170090009","article-title":"Infectious complications in heart-lung transplantation","volume":"153","author":"Kromer","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.healun.2003.05.002_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1053-2498(01)00680-5","article-title":"Clinical utility of cyclosporin C2 monitoring after lung transplantation (LTx)","volume":"21","author":"Glanville","year":"2002","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 3","key":"10.1016\/j.healun.2003.05.002_bib26","first-page":"233","article-title":"C2 monitoring in stable renal transplant recipients may reduce cyclosporine nephrotoxicity","volume":"2","author":"Cole","year":"2002","journal-title":"Am J Transplant"},{"issue":"suppl 3","key":"10.1016\/j.healun.2003.05.002_bib27","first-page":"370","article-title":"Long term follow up of maintenance liver transplant patients converted to C2 cyclosporine using Neoral immunosuppression","volume":"2","author":"Levy","year":"2002","journal-title":"Am J Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249804003894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249804003894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:11:16Z","timestamp":1760947876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249804003894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S1053249804003894"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2003.05.002","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring C2 Level Predicts Exposure in Maintenance Lung Transplant Patients Receiving the Microemulsion Formulation of Cyclosporine (Neoral)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2003.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}